Finance

Lists
CBT:NYSE
Cabot Corp
$77.70
+1.77%
(+1.35) 1D
Oct 2, 11:44:51 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CBT...
Open
$77.67
High
$78.68
Low
$77.23
Mkt. cap
4.01B
Avg. vol.
384.87K
Volume
54.28K
Dividend
2.43%
Quarterly dividend
$0.47
Ex-dividend date
Aug 28, 2026
P/E ratio
21.93
52-wk high
$94.53
52-wk low
$58.33
EPS
$3.54
Beta
0.83
Shares outstanding
51.63M
No. of employees
4K
Open
$77.67
High
$78.68
Low
$77.23
Mkt. cap
4.01B
Avg. vol.
384.87K
Volume
54.28K
Dividend
2.43%
Quarterly dividend
$0.47
Ex-dividend date
Aug 28, 2026
P/E ratio
21.93
52-wk high
$94.53
52-wk low
$58.33
EPS
$3.54
Beta
0.83
Shares outstanding
51.63M
No. of employees
4K
News stories
From web sources and news partners
Profile
Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices. Wikipedia
About Cabot Corp
CEOSean D. Keohane
Employees4.06K
Founded1882
HeadquartersBoston, Massachusetts, United States
SectorCommodity chemical
Websitecabotcorp.com
Analyst ratings
Based on 4 analysts giving stock ratings to CBT in the past 3 months
Hold
Buy
2
Hold
1
Sell
1
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CBT in the last 3 months.
Highest
Current $77.70
$98.00 (+26.13%)
Average
$89.33 (+14.97%)
Lowest
$78.00 (+0.39%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Jefferies
Buy
Maintained
$98.00
+26.1%
09/22/2026
Jeffrey Zekauskas
J.P. Morgan
Sell
Maintained
$78.00
+0.4%
08/10/2026
Pete Osterland
Truist Financial
Buy
Maintained
-
-
08/10/2026
Joshua Spector
UBS
Hold
Maintained
$92.00
+18.4%
08/05/2026
John Roberts CFA
Mizuho Securities
Hold
Maintained
$90.00
+15.8%
06/25/2026
David Begleiter
Deutsche Bank
Hold
Maintained
$80.00
+3%
03/02/2026
Last report
Aug 4, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$1.67 / $1.66
+0.71%beat
Revenue / Est. (USD)
982.00M / 949.70M
+3.40%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
899.00M
849.00M
904.00M
982.00M
Cost of goods sold
673.00M
632.00M
687.00M
758.00M
Cost of revenue
673.00M
632.00M
687.00M
758.00M
Research and development expenses
13.00M
13.00M
14.00M
13.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
64.00M
68.00M
65.00M
71.00M
Operating expense
77.00M
81.00M
79.00M
84.00M
Total operating expenses
750.00M
713.00M
766.00M
842.00M
Operating income
149.00M
136.00M
138.00M
140.00M
Other non operating income
-5.00M
-
2.00M
-1.00M
EBT including unusual items
117.00M
119.00M
122.00M
60.00M
EBT excluding unusual items
130.00M
126.00M
131.00M
131.00M
Income tax expense
63.00M
37.00M
44.00M
46.00M
Effective tax rate
53.85%
31.09%
36.07%
76.67%
Other operating expenses
-
-
-
-
Net income
43.00M
73.00M
68.00M
6.00M
Net profit margin
4.78%
8.60%
7.52%
0.61%
Earnings per share
1.70
1.53
1.61
1.67
Interest and investment income
7.00M
7.00M
7.00M
8.00M
Interest expense
-20.00M
-18.00M
-18.00M
-18.00M
Net interest expenses
-13.00M
-11.00M
-11.00M
-10.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
189.00M
177.00M
187.00M
190.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps